We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genzyme To Cough Up $64M To Settle Suit

Law360 (August 10, 2007, 12:00 AM EDT) -- Biotechnology company Genzyme Corp. will pay $64 million to settle a four-year-long squabble with shareholders over changes to the company's stock structure.

The settlement, which has yet to be filed in the U.S. District Court for the Southern District of New York, still needs court approval.

The company announced the deal in the class action on Thursday, saying that settling was in the best interests of all the parties.

Genzyme said, though, it still believes that its contested consolidation of the company's tracking stock structure “was...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.